Lexicon Pharmaceuticals Inc (LXRX)
1.60
-0.01
(-0.62%)
USD |
NASDAQ |
Apr 24, 16:00
1.595
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals Total Liabilities (Quarterly): 136.32M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 136.32M |
| September 30, 2023 | 136.97M |
| June 30, 2023 | 130.36M |
| March 31, 2023 | 74.67M |
| December 31, 2022 | 77.18M |
| September 30, 2022 | 47.67M |
| June 30, 2022 | 41.50M |
| March 31, 2022 | 43.48M |
| December 31, 2021 | 23.31M |
| September 30, 2021 | 35.73M |
| June 30, 2021 | 34.44M |
| March 31, 2021 | 40.71M |
| December 31, 2020 | 47.42M |
| September 30, 2020 | 91.29M |
| June 30, 2020 | 333.23M |
| March 31, 2020 | 315.79M |
| December 31, 2019 | 300.61M |
| September 30, 2019 | 279.88M |
| June 30, 2019 | 298.03M |
| March 31, 2019 | 304.20M |
| December 31, 2018 | 310.54M |
| September 30, 2018 | 339.59M |
| June 30, 2018 | 338.01M |
| March 31, 2018 | 360.62M |
| December 31, 2017 | 368.27M |
| Date | Value |
|---|---|
| September 30, 2017 | 251.11M |
| June 30, 2017 | 257.20M |
| March 31, 2017 | 261.66M |
| December 31, 2016 | 318.22M |
| September 30, 2016 | 331.76M |
| June 30, 2016 | 340.80M |
| March 31, 2016 | 358.46M |
| December 31, 2015 | 366.11M |
| September 30, 2015 | 193.20M |
| June 30, 2015 | 184.49M |
| March 31, 2015 | 187.08M |
| December 31, 2014 | 187.36M |
| September 30, 2014 | 109.70M |
| June 30, 2014 | 107.40M |
| March 31, 2014 | 102.82M |
| December 31, 2013 | 104.00M |
| September 30, 2013 | 113.75M |
| June 30, 2013 | 108.31M |
| March 31, 2013 | 105.07M |
| December 31, 2012 | 105.10M |
| September 30, 2012 | 105.08M |
| June 30, 2012 | 136.16M |
| March 31, 2012 | 133.82M |
| December 31, 2011 | 132.94M |
| September 30, 2011 | 125.22M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
23.31M
Minimum
Dec 2021
333.23M
Maximum
Jun 2020
130.98M
Average
77.18M
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
| Novavax Inc | 2.514B |
| AIM ImmunoTech Inc | 9.147M |
| Perspective Therapeutics Inc | 22.71M |
| Protalix BioTherapeutics Inc | 50.86M |
| Armata Pharmaceuticals Inc | 130.43M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 229.43M |
| Shareholders Equity (Quarterly) | 93.11M |
| Debt to Equity Ratio | 1.069 |
| Current Ratio | 5.596 |
| Net Debt Paydown Yield | -4.04% |